These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 815533)
21. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection. García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305 [TBL] [Abstract][Full Text] [Related]
22. [Antigens of the subcellular fractions of Trypanosoma cruzi. I. Localization of antigens and proteins in the subcellular fractions]. Segura EL; Campos JM; de Ducatenzeiler AB; Cerisola JA Medicina (B Aires); 1975; 35(5):451-9. PubMed ID: 55942 [No Abstract] [Full Text] [Related]
23. Experimental Chagas' disease in mice infected with one LD50 of parasite. Repka D; Rangel HA; Atta AM; Gavino VA; Piedrabuena AE Rev Bras Biol; 1985 Aug; 45(3):309-16. PubMed ID: 3938552 [No Abstract] [Full Text] [Related]
28. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice. Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297 [TBL] [Abstract][Full Text] [Related]
29. Cellular immunity in Chagas' disease patients. Lymphoproliferative response to subcellular fractions of Trypanosoma cruzi. De Titto EH; Segura EL; Braun M Immunol Lett; 1983 Mar; 6(3):161-7. PubMed ID: 6407983 [TBL] [Abstract][Full Text] [Related]
30. A novel and basic mechanism of immunosuppression in Chagas' disease: Trypanosoma cruzi releases in vitro and in vivo a protein which induces T cell unresponsiveness through specific interaction with cysteine and glutathione. Ouaissi A; Guevara-Espinoza A; Chabé F; Gomez-Corvera R; Taibi A Immunol Lett; 1995 Dec; 48(3):221-4. PubMed ID: 8867855 [No Abstract] [Full Text] [Related]
31. Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: role of nitric oxide. Pinge-Filho P; Peron JP; de Moura TR; Menolli RA; Graça VK; Estevão D; Tadokoro CE; Jankevicius JV; Rizzo LV Immunol Lett; 2005 Jan; 96(2):283-90. PubMed ID: 15585334 [TBL] [Abstract][Full Text] [Related]
35. Experiments on immunoprophylaxis against Chagas' disease. Hanson WL Adv Exp Med Biol; 1977; 93():281-3. PubMed ID: 413342 [No Abstract] [Full Text] [Related]
36. Purification and properties of anti-Trypanosoma cruzi antibodies isolated from patients with chronic Chagas' disease. Hajos SE; Carbonetto C; Margni RA; Esteva M; Segura EL Immunol Lett; 1982 Apr; 4(4):199-203. PubMed ID: 6807842 [TBL] [Abstract][Full Text] [Related]
37. Flagellar antigens and the leucocyte migration-inhibition test in Chagas patients. Patrucco A; Cerisola JA; Michel M; Chiale P; Alvarez M; Segura EL Trans R Soc Trop Med Hyg; 1978; 72(4):425-6. PubMed ID: 100910 [No Abstract] [Full Text] [Related]
38. Trypanosoma cruzi: protective immunization of susceptible strains of mice prone to autoimmunity. Nickell SP; Boyer MH Exp Parasitol; 1986 Dec; 62(3):450-2. PubMed ID: 3096772 [No Abstract] [Full Text] [Related]
39. The effect of BCG on the course of experimental Chagas' disease in mice. Kuhn RE; Vaughn RT; Herbst GA Int J Parasitol; 1975 Oct; 5(5):557-60. PubMed ID: 808508 [No Abstract] [Full Text] [Related]
40. Effect of sex of mice in relation to their response to immunization with vaccines prepared from Trypanosoma cruzi. McHardy N Trans R Soc Trop Med Hyg; 1978; 72(2):201-2. PubMed ID: 418539 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]